Skip to content

Treatment of Hidradenitis Suppurativa with a blue light (415 nm) and red light(633 nm) combination PDT

Treatment of Hidradenitis Suppurativa with a blue light (415 nm) and red light(633 nm) combination PDT - Hidradenitis blue-red light combination PDT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31302
Enrollment
11
Registered
2007-10-30
Start date
2007-11-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne inversa hidradenitis suppurativa

Interventions

Every patient has at least one treatment- control combination with the same Hurley classification. Every Hurley- combination consist of a treatment area and a control are. Treatment with: Omnilux Bl

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Suffering from hidradenitis suppurativa. 18-45 years old. In case of oral medication/ anticonceptives: use of at least 6 months and intention te continue use during study.

Exclusion criteria

Exclusion criteria: -Oral medication for HS in last 2 months -In menopause or postmenopausal -Intention to use anticonceptives -Previous external or oral use of isotretinoine in last 6 months -Oral/ local anti-inflammatory medication during the last 4 weeks -Epilepsy -Pregnancy, breastfeeding, intention to conceive -Photosensitivity -Use of photosensitive medication -treatment for cancer in the past, history of skincancer, presence of premaligne lesions -Use of anticoagulants, suffering from a clotting-disease. -Surgical operations in the treatment areas in the past 6 months -recently had PDT for HS -Recent suntanning or planning to

Design outcomes

Primary

MeasureTime frame
Reduction Sartorius score reduction unidimensional visual painscore

Secondary

MeasureTime frame
Time to improvement individual laesions Time to improvement painscale scores Treatment experience satisfaction side effects visual improvements on photo's

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)